Laser and phototherapy of rosacea
- Authors: Matushevskaya Y.I.1
-
Affiliations:
- Lyubertsy Skin and Venereological Dispensary
- Issue: Vol 21, No 5 (2022)
- Pages: 349-358
- Section: Review
- URL: https://journals.rcsi.science/1681-3456/article/view/131060
- DOI: https://doi.org/10.17816/rjpbr115248
- ID: 131060
Cite item
Abstract
Rosacea is a non-infectious dermatological disease of middle age, requiring long-term and often lifelong treatment. The onset of the disease begins with minor clinical manifestations such as centrofacial transient erythema or conjunctivitis, which patients often do not consider as a need to consult a doctor.
Early therapy prevents the chronization of the process and the development of severe forms, which include papulo-pustular rosacea, ophthalmosacea and phymes.
One of the methods of rosacea treatment is physiotherapy, which includes laser light, cryotherapy, darsonvalization, electrophoresis, electrocoagulation, pulse therapy, inductothermy, phototherapy of vascular pathology, and others.
This review presents the main mechanisms of laser light action on human skin and systematizes recent data on its use in various forms of rosacea.
Despite the moderate success of laser therapy, further research will help to choose more effective treatment protocols for rosacea. The appearance of the first signs of vasodilation in the facial area, especially in people with a family history of rosacea, frequent eye diseases or the presence of fim, requires contacting a dermatologist.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Yuliya I. Matushevskaya
Lyubertsy Skin and Venereological Dispensary
Author for correspondence.
Email: yuliya-matushevskaya@yandex.ru
ORCID iD: 0000-0001-5995-6689
SPIN-code: 3238-9093
MD, Cand. Sci. (Med.)
Russian Federation, LyubertsyReferences
- Yazici AC, Tamer L, Ikizoglu G, et al. GSTM1 and GSTT1 null geno types as possible heritable factors of rosacea. Photodermatol. Photoimmunol Photomed. 2006;22:208–210. doi: 10.1111/j.1600-0781.2006.00220.x
- Srivastava DS, Jain VK, Verma P, Yadav JP. Polymorphism of glutathione S-transferase M1 and T1 genes and susceptibility to psoriasis disease: A study from North India. Indian J Dermatol Venereol Leprol. 2018;84(1):39–44. doi: 10.4103/ijdvl.IJDVL_1128_16
- Guo H, Huang Y, Wu J, et al. Correlation analysis of the HLA-DPB1*05:01 and BTNL2 genes within the histocompatibility complex region with a clinical phenotype of psoriasis vulgaris in the Chinese Han population. J Gene Med. 2017;19(9-10). doi: 10.1002/jgm.2961
- Chang AL, Raber I, Xu J, et al. Assessment of the genetic basis of rosacea by genome-wide association study. J Invest Dermatol. 2015;135(6):1548–1555. doi: 10.1038/jid.2015.53
- Rhodes DA, Reith W, Trowsdale J. Regulation of immunity by butyrophilins. Annu Rev Immunol. 2016;34:151–172. doi: 10.1146/annurev-immunol-041015-055435
- Chaperon M, Pacheco Y, Maucort-Boulch D, et al. BTNL2 gene polymorphism and sarcoid uveitis. Br J Ophthalmol. 2019. pii: bjophthalmol-2018-312949. doi: 10.1136/bjophthalmol-2018-312949
- Tolentino YF, Elia PP, Fogaça HS, et al. Common NOD2/CARD15 and TLR4 polymorphisms are associated with Crohn's disease phenotypes in southeastern Brazilians. Dig Dis Sci. 2016;61(9):2636–2647. doi: 10.1007/s10620-016-4172-8
- Marrani E, Cimaz R, Lucherini OM, et al. The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: A cohort study. Pediatr Rheumatol Online J. 2015;13(1):38. doi: 10.1186/s12969-015-0037-5
- Angeletti S, Galluzzo S, Santini D, et al. NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population. Hum Immunol. 2009;70(9):729–732. doi: 10.1016/j.humimm.2009.04.026
- Salzer S, Kresse S, Hirai Y, et al. Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: Possible implications for rosacea. J Dermatol Sci. 2014;76(3):173–179. doi: 10.1016/j.jdermsci.2014.09.002
- Yamasaki K, Gallo RL. Rosacea as a disease of cathelicidins and skin innate immunity. J Investig Dermatol Symp Proc. 2011;15(1):12–15. doi: 10.1038/jidsymp.2011.4
- Gökçınar NB, Karabulut AA, Onaran Z, et al. Elevated tear human neutrophil peptides 1-3, human beta defensin-2 levels and conjunctival cathelicidin LL-37 gene expression in ocular rosacea. Ocul Immunol Inflamm. 2019;27(7):1174–1183. doi: 10.1080/09273948.2018.1504971
- Yamasaki K, Kanada K, Macleod DT, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol. 2011;131(3):688–697. doi: 10.1038/jid.2010.351
- Meyer-Hoffert U, Schröder JM. Epidermal proteases in the pathogenesis of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):16–23. doi: 10.1038/jidsymp.2011.2
- Muto Y, Wang Z, Vanderberghe M, et al. Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea. J Invest Dermatol. 2014;134(11):2728–2736. doi: 10.1038/jid.2014.222
- Zaidi AK, Spaunhurst K, Sprockett D, et al. Characterization of the facial microbiome in twins discordant for rosacea. Exp Dermatol. 2018;27(3):295–298. doi: 10.1111/exd.13491
- Clanner-Engelshofen BM, Bernhard D, Dargatz S, et al. S2k guideline: Rosacea. J Dtsch Dermatol Ges. 2022;20(8):1147–1165. doi: 10.1111/ddg.14849
- Searle T, Ali FR, Carolides S, Al-Niaimi F. Rosacea and diet: What is new in 2021? J Clin Aesthet Dermatol. 2021;14(12):49–54.
- Silverman HA, Chen A, Kravatz NL, et al. Involvement of neural transient receptor potential channels in peripheral inflammation. Front Immunol. 2020;11:590261. doi: 10.3389/fimmu.2020.590261
- Ziolkowski N, Kitto SC, Jeong D, et al. Psychosocial and quality of life impact of scars in the surgical, traumatic and burn populations: A scoping review protocol. BMJ Open. 2019;9(6):e021289. doi: 10.1136/bmjopen-2017-021289
- Anderson RR, Parrish JA. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524–527. doi: 10.1126/science.6836297
- Alam M, Voravutinon N, Warycha M, et al. Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: A double-blind randomized controlled trial. J Am Acad Dermatol. 2013;69(3):438–443. doi: 10.1016/j.jaad.2013.04.015
- Campos MA, Sousa AC, Varela P, et al. Comparative effectiveness of purpuragenic 595 nm pulsed dye laser versus sequential emission of 595 nm pulsed dye laser and 1,064 nm Nd:YAG laser: A double-blind randomized controlled study. Acta Dermatovenerol Alp Pannonica Adriat. 2019;28(1):1–5.
- Kwon WJ, Park BW, Cho EB, et al. Comparison of efficacy between long-pulsed Nd:YAG laser and pulsed dye laser to treat rosacea-associated nasal telangiectasia. J Cosmet Laser Ther. 2018;20(5):260–264. doi: 10.1080/14764172.2017.1418510
- Salem SA, Abdel Fattah NS, Tantawy SM, et al. Neodymium-yttrium aluminum garnet laser versus pulsed dye laser in erythemato-telangiectatic rosacea: Comparison of clinical efficacy and effect on cutaneous substance (P) expression. J Cosmet Dermatol. 2013;12(3):187–194. doi: 10.1111/jocd.12048
- Handler MZ, Bloom BS, Goldberg DJ. IPL vs PDL in treatment of facial erythema: A split-face study. J Cosmet Dermatol. 2017;16(4):450–453. doi: 10.1111/jocd.12365
- Kim BY, Moon HR, Ryu HJ. Comparative efficacy of short-pulsed intense pulsed light and pulsed dye laser to treat rosacea. J Cosmet Laser Ther. 2019;21(5):291–296. doi: 10.1080/14764172.2018.1528371
- Neuhaus IM, Zane LT, Tope WD. Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea. Dermatol Surg. 2009;35(6):920–928. doi: 10.1111/j.1524-4725.2009.01156.x
- Nymann P, Hedelund L, Haedersdal M. Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: A randomized controlled trial. J Eur Acad Dermatol Venereol. 2010;24(2):143–146. doi: 10.1111/j.1468-3083.2009.03357.x
- Tanghetti EA. Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece. Lasers Surg Med. 2012;44(2):97–102. doi: 10.1002/lsm.21151
- West TB, Alster TS. Comparison of the long-pulse dye (590–595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol Surg. 1998;24(2):221–226. doi: 10.1111/j.1524-4725.1998.tb04140.x
- Kim SJ, Lee Y, Seo YJ, et al. Comparative efficacy of radiofrequency and pulsed dye laser in the treatment of rosacea. Dermatol Surg. 2017;43(2):204–209. doi: 10.1097/DSS.0000000000000968
- Kruglova LS, Kotenko KV, Korchazhkina NB, Turbovskaya SN. Physiotherapy in dermatology. Moscow: GEOTAR-Media; 2016. 304 p. (In Russ).
- Paasch U, Zidane M, Baron JM, et al. S2k guideline: Laser therapy of the skin. J Dtsch Dermatol Ges. 2022;20(9):1248–1267. doi: 10.1111/ddg.14879
- Husein-ElAhmed H, Steinhoff M. Light-based therapies in the management of rosacea: A systematic review with meta-ana lysis. Int J Dermatol. 2022;61(2):216–225. doi: 10.1111/ijd.15680
- Luo Y, Luan XL, Zhang JH, et al. Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm-wavelength intense pulsed light: A prospective randomized controlled trial with a 2-year follow-up. Exp Ther Med. 2020;19(6):3543–3550. doi: 10.3892/etm.2020.8617
- Liu J, Liu J, Ren Y, et al. Comparative efficacy of intense pulsed light for different erythema associated with rosacea. J Cosmet Laser Ther. 2014;16(6):324–327. doi: 10.3109/14764172.2014.957218
- Sharshunova AA, Kruglova LS, Kotenko KV, Sofinskaya GV. Etiopathogenesis and possibilities of laser therapy of erythematous-telangiectatic subtype of rosacea. Russian journal of the physial therapy, balneotherapy and rehabilitation. 2017;16(6):284–290. doi: 10.18821/1681-3456-2017-16-6-284-290
- Toyos R, Desai NR, Toyos M, Dell SJ. Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: A randomized controlled study. PLoS One. 2022;17(6):e0270268. doi: 10.1371/journal.pone.0270268
- Amaral MT, Haddad A, Nahas FX, et al. Impact of fractional ablative carbon dioxide laser on the treatment of rhinophyma. Aesthet Surg J. 2019;39(4):NP68–NP75. doi: 10.1093/asj/sjy234
- Kassirer SS, Gotkin RH, Sarnoff DS. Treatment of rhinophyma with fractional CO2 laser resurfacing in a woman of color: Case report and review of the literature. J Drugs Dermatol. 2021;20(7):772–775. doi: 10.36849/JDD.C702
- Bassi A, Campolmi P, Dindelli M, et al. Laser surgery in rhinophyma. G Ital Dermatol Venereol. 2016;151(1):9–16.
- Badawi A, Osman M, Kassab A. Novel management of rhinophyma by patterned ablative 2940 nm Erbium:YAG laser. Clin Cosmet Investig Dermatol. 2020;13:949–955. doi: 10.2147/CCID.S286847
- Li A, Fang R, Mao X, Sun Q. Photodynamic therapy in the treatment of rosacea: A systematic review. Photodiagnosis Photodyn Ther. 2022;38:102875. doi: 10.1016/j.pdpdt.2022.102875
- Friedmann DP, Goldman MP, Fabi SG, Guiha I. Multiple sequential light and laser sources to activate aminolevulinic acid for rosacea. J Cosmet Dermatol. 2016;15(4):407–412. doi: 10.1111/jocd.12231